Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-17-029621

Director bought 11,000 shares at $2.71 ($29,810)

From the SEC's structured data for this filing

Trades in this filing

MITCHELL DANIEL J · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-05-02 Purchase : show line 1 in the form +11,000 $2.71 $29,810 11,000 D
Open-market purchases · 11,000 sh · avg $2.71 · $29,810
Loading xslF345X03/doc4.xml…